Dec 14, 2025, 13:55
Indunil Karunarathna: Anticoagulation Therapy in Atrial Fibrillation Risks and Benefits
Indunil Karunarathna, Consultant Anaesthetist, Head of the Department, T H Polonnaruwa, Ministry of Health, Sri Lanka, posted on LinkedIn:
“Anticoagulation Therapy in Atrial Fibrillation Risks and Benefits
Book
September 2024
Indunil Karunarathna”
Title: Anticoagulation Therapy in Atrial Fibrillation Risks and Benefits
Authors: Indunil Karunarathna, K Gunawardana, Sandya Rajapaksha, A Warnakulasooriya, P Athulgama, Sanjeewa Dius, R Ranwala, U Vidanagama, Sanjaya Godage, Rodrigo Pn, C Fernando, U Ekanayake, T Hapuarachchi, P Gunasena, P Aluthge, Navoda Perera, S Gunathilake, Kapila De Alvis, Sau Bandara, Asoka Jayawardana
Read the full paper here.
Stay updated with Hemostasis Today.
A Warnakulasooriya
Anticoagulation Therapy
Asoka Jayawardana
Atrial Fibrillation
C Fernando
Health
Hemostasis
Hemostasis Today
Indunil Karunarathna
K Gunawardana
Kapila De Alvis
Medicine
Navoda Perera
P Aluthge
P Athulgama
P Gunasena
R Ranwala
Rodrigo Pn
S Gunathilake
Sandya Rajapaksha
Sanjaya Godage
Sanjeewa Dius
Sau Bandara
T Hapuarachchi
thrombosis
U Ekanayake
U Vidanagama
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis